project id: TCGA-UCEC; case submitter id: TCGA-AX-A0J1; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.2; rna integrity number: 8.2; age at index: 80; days to birth: -29501; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1925; age at diagnosis: 29501; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 2354.0; figo stage: Stage IB; icd 10 code: C54.1; last known disease status: not reported; morphology: 8380/3; primary diagnosis: Endometrioid adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Endometrium; synchronous malignancy: No; tissue or organ of origin: Endometrium; tumor grade: Not Reported; year of diagnosis: 2005; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 1721; days to sample procurement: 0; initial weight: 220.0; portion submitter id: TCGA-AX-A0J1-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0;